Moleculin Biotech, Inc. (MBRX) › Operating IncomeMoleculin Biotech, Inc. (MBRX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$3.88M2017: -$8.65M2018: -$15.03M2019: -$17.52M2020: -$19.74M2021: -$22.97M2022: -$30.64M2023: -$29.63M2024: -$26.64M2025: -$25.10M-$25.10M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$25.10M+5.8%2024-$26.64M+10.1%2023-$29.63M+3.3%2022-$30.64M-33.4%2021-$22.97M-16.3%2020-$19.74M-12.7%2019-$17.52M-16.6%2018-$15.03M-73.6%2017-$8.65M-122.8%2016-$3.88M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share